Dynavax (DVAX) – FDA
-
Dynavax (DVAX) Announces Great Britain Marketing Authorization for HEPLISAV B
-
Clover’s COVID-19 Vaccine Candidate Demonstrates Strong Cross-Neutralization Against Omicron as a Homologous Booster
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to DVAX Stock Lookup